Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Centene Co. stock logo
CNC
Centene
$75.68
-0.7%
$76.42
$60.83
$81.42
$40.75B0.383.05 million shs3.64 million shs
Elevance Health, Inc. stock logo
ELV
Elevance Health
$539.70
+1.1%
$511.40
$412.00
$542.07
$124.05B0.781.13 million shs1.07 million shs
Humana Inc. stock logo
HUM
Humana
$311.41
-1.4%
$328.56
$299.23
$541.21
$38.12B0.451.90 million shs1.84 million shs
Moderna, Inc. stock logo
MRNA
Moderna
$106.18
-2.5%
$102.15
$62.55
$142.79
$41.68B1.623.00 million shs2.80 million shs
7 Stocks to Buy And Hold Forever Cover

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Centene Co. stock logo
CNC
Centene
-0.68%+2.61%-2.43%+2.58%+13.57%
Elevance Health, Inc. stock logo
ELV
Elevance Health
+1.11%+2.76%+4.40%+11.57%+19.30%
Humana Inc. stock logo
HUM
Humana
-1.47%-4.13%-10.61%-13.79%-38.39%
Moderna, Inc. stock logo
MRNA
Moderna
-2.45%+4.10%-1.15%+4.29%-18.77%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Centene Co. stock logo
CNC
Centene
4.7902 of 5 stars
2.35.00.03.93.72.53.1
Elevance Health, Inc. stock logo
ELV
Elevance Health
4.4223 of 5 stars
2.55.04.20.03.22.52.5
Humana Inc. stock logo
HUM
Humana
4.9984 of 5 stars
4.23.03.33.93.03.33.1
Moderna, Inc. stock logo
MRNA
Moderna
4.0179 of 5 stars
3.12.00.04.61.83.30.6

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Centene Co. stock logo
CNC
Centene
2.55
Moderate Buy$85.2512.65% Upside
Elevance Health, Inc. stock logo
ELV
Elevance Health
2.92
Moderate Buy$587.428.84% Upside
Humana Inc. stock logo
HUM
Humana
2.47
Hold$433.7439.28% Upside
Moderna, Inc. stock logo
MRNA
Moderna
2.25
Hold$126.4919.12% Upside

Current Analyst Ratings

Latest HUM, CNC, ELV, and MRNA Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/25/2024
Humana Inc. stock logo
HUM
Humana
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$415.00 ➝ $353.00
4/25/2024
Humana Inc. stock logo
HUM
Humana
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$391.00 ➝ $360.00
4/25/2024
Humana Inc. stock logo
HUM
Humana
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$334.00 ➝ $326.00
4/25/2024
Humana Inc. stock logo
HUM
Humana
Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$415.00 ➝ $370.00
4/24/2024
Elevance Health, Inc. stock logo
ELV
Elevance Health
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$575.00 ➝ $585.00
4/22/2024
Humana Inc. stock logo
HUM
Humana
Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$411.00 ➝ $381.00
4/19/2024
Elevance Health, Inc. stock logo
ELV
Elevance Health
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$574.00 ➝ $575.00
4/19/2024
Elevance Health, Inc. stock logo
ELV
Elevance Health
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$585.00 ➝ $605.00
4/19/2024
Elevance Health, Inc. stock logo
ELV
Elevance Health
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$580.00 ➝ $600.00
4/19/2024
Elevance Health, Inc. stock logo
ELV
Elevance Health
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$557.00 ➝ $600.00
4/19/2024
Elevance Health, Inc. stock logo
ELV
Elevance Health
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$584.00 ➝ $621.00
(Data available from 4/26/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Centene Co. stock logo
CNC
Centene
$154.00B0.26$9.18 per share8.24$48.55 per share1.56
Elevance Health, Inc. stock logo
ELV
Elevance Health
$171.34B0.73$41.71 per share12.94$175.16 per share3.08
Humana Inc. stock logo
HUM
Humana
$106.37B0.35$33.78 per share9.22$134.15 per share2.32
Moderna, Inc. stock logo
MRNA
Moderna
$6.85B5.94N/AN/A$36.33 per share2.92

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Centene Co. stock logo
CNC
Centene
$2.70B$4.9115.4110.010.951.75%14.26%4.36%4/26/2024 (Confirmed)
Elevance Health, Inc. stock logo
ELV
Elevance Health
$5.99B$26.4620.4012.991.183.64%20.62%7.35%7/17/2024 (Estimated)
Humana Inc. stock logo
HUM
Humana
$2.49B$16.0619.3913.981.851.82%17.76%5.63%8/7/2024 (Estimated)
Moderna, Inc. stock logo
MRNA
Moderna
-$4.71B-$12.41N/AN/AN/A-68.84%-10.23%-7.70%5/2/2024 (Confirmed)

Latest HUM, CNC, ELV, and MRNA Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/2/2024N/A
Moderna, Inc. stock logo
MRNA
Moderna
-$3.36N/A+$3.36N/AN/AN/A  
4/26/2024Q1 24
Centene Co. stock logo
CNC
Centene
$2.20$2.26+$0.06N/AN/AN/A  
4/24/2024Q1 24
Humana Inc. stock logo
HUM
Humana
$6.12$7.23+$1.11$8.35$28.52 billion$29.61 billion      
4/18/2024Q1 2024
Elevance Health, Inc. stock logo
ELV
Elevance Health
$10.54$10.64+$0.10$11.69$42.49 billion$42.27 billion      
2/22/2024Q4 2023
Moderna, Inc. stock logo
MRNA
Moderna
-$0.78$0.55+$1.33$0.55$2.53 billion$2.80 billion    
2/6/202412/31/2023
Centene Co. stock logo
CNC
Centene
$0.43$0.45+$0.02$0.82$36.16 billion$39.46 billion    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Centene Co. stock logo
CNC
Centene
N/AN/AN/AN/AN/A
Elevance Health, Inc. stock logo
ELV
Elevance Health
$6.521.21%+15.93%24.64%13 Years
Humana Inc. stock logo
HUM
Humana
$3.541.14%+12.29%22.04%7 Years
Moderna, Inc. stock logo
MRNA
Moderna
N/AN/AN/AN/AN/A

Latest HUM, CNC, ELV, and MRNA Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/18/2024
Humana Inc. stock logo
HUM
Humana
quarterly$0.88501.09%6/28/20246/28/20247/26/2024
4/19/2024
Elevance Health, Inc. stock logo
ELV
Elevance Health
quarterly$1.631.2%6/10/20246/10/20246/25/2024
2/15/2024
Humana Inc. stock logo
HUM
Humana
quarterly$0.88500.97%3/27/20243/29/20244/26/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Centene Co. stock logo
CNC
Centene
0.68
1.11
1.11
Elevance Health, Inc. stock logo
ELV
Elevance Health
0.54
1.37
1.37
Humana Inc. stock logo
HUM
Humana
0.77
1.67
1.59
Moderna, Inc. stock logo
MRNA
Moderna
0.04
3.42
3.36

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Centene Co. stock logo
CNC
Centene
93.63%
Elevance Health, Inc. stock logo
ELV
Elevance Health
89.24%
Humana Inc. stock logo
HUM
Humana
92.38%
Moderna, Inc. stock logo
MRNA
Moderna
75.33%

Insider Ownership

CompanyInsider Ownership
Centene Co. stock logo
CNC
Centene
0.33%
Elevance Health, Inc. stock logo
ELV
Elevance Health
0.35%
Humana Inc. stock logo
HUM
Humana
0.32%
Moderna, Inc. stock logo
MRNA
Moderna
15.70%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Centene Co. stock logo
CNC
Centene
67,700534.91 million533.14 millionOptionable
Elevance Health, Inc. stock logo
ELV
Elevance Health
104,900232.42 million231.61 millionOptionable
Humana Inc. stock logo
HUM
Humana
67,600120.65 million120.27 millionOptionable
Moderna, Inc. stock logo
MRNA
Moderna
5,600382.88 million322.77 millionOptionable

HUM, CNC, ELV, and MRNA Headlines

SourceHeadline
California Public Employees Retirement System Lowers Stake in Moderna, Inc. (NASDAQ:MRNA)California Public Employees Retirement System Lowers Stake in Moderna, Inc. (NASDAQ:MRNA)
marketbeat.com - April 26 at 7:36 AM
Should You Buy Moderna Before May 12?Should You Buy Moderna Before May 12?
fool.com - April 26 at 4:50 AM
Moderna cancer vaccine offers long-term hope in melanomaModerna cancer vaccine offers long-term hope in melanoma
proactiveinvestors.co.uk - April 26 at 4:06 AM
How Is The Market Feeling About Moderna?How Is The Market Feeling About Moderna?
benzinga.com - April 26 at 3:49 AM
British patients test world’s first personalised MRNA cancer jab for melanomaBritish patients test world’s first personalised MRNA cancer jab for melanoma
yahoo.com - April 26 at 3:49 AM
Cancer cure hope as UK patients trial world’s first personalised mRNA vaccine for melanomaCancer cure hope as UK patients trial world’s first personalised mRNA vaccine for melanoma
msn.com - April 26 at 3:49 AM
British patients test world’s first personalised mRNA jab for melanomaBritish patients test world’s first personalised mRNA jab for melanoma
expressandstar.com - April 25 at 10:49 PM
Stevens Capital Management LP Cuts Stake in Moderna, Inc. (NASDAQ:MRNA)Stevens Capital Management LP Cuts Stake in Moderna, Inc. (NASDAQ:MRNA)
marketbeat.com - April 25 at 6:01 PM
Modernas CEO wants employees to use ChatGPT at least 20 times a dayModerna's CEO wants employees to use ChatGPT at least 20 times a day
msn.com - April 25 at 5:47 PM
Moderna lifts lid on OpenAI artificial intelligence collabModerna lifts lid on OpenAI artificial intelligence collab
thepharmaletter.com - April 25 at 5:47 PM
Moderna Employees Should Use ChatGPT at Least 20 Times a Day, CEO SaysModerna Employees Should Use ChatGPT at Least 20 Times a Day, CEO Says
msn.com - April 25 at 5:47 PM
Analysts Estimate Moderna (MRNA) to Report a Decline in Earnings: What to Look Out forAnalysts Estimate Moderna (MRNA) to Report a Decline in Earnings: What to Look Out for
zacks.com - April 25 at 11:05 AM
Moderna, Inc.: Moderna To Present Respiratory & Cytomegalovirus Research at the ESCMID Global CongressModerna, Inc.: Moderna To Present Respiratory & Cytomegalovirus Research at the ESCMID Global Congress
finanznachrichten.de - April 25 at 8:26 AM
Moderna To Present Respiratory & Cytomegalovirus Research at the ESCMID Global CongressModerna To Present Respiratory & Cytomegalovirus Research at the ESCMID Global Congress
accesswire.com - April 25 at 7:00 AM
Moderna (MRNA) to Release Earnings on ThursdayModerna (MRNA) to Release Earnings on Thursday
americanbankingnews.com - April 25 at 3:42 AM
Sycomore Asset Management Invests $4.67 Million in Moderna, Inc. (NASDAQ:MRNA)Sycomore Asset Management Invests $4.67 Million in Moderna, Inc. (NASDAQ:MRNA)
marketbeat.com - April 24 at 10:27 PM
How mRNA Is Rewriting the Rules of Cancer TreatmentHow mRNA Is Rewriting the Rules of Cancer Treatment
scitechdaily.com - April 24 at 10:24 PM
Moderna partners with OpenAI to supercharge mRNA research with genAIModerna partners with OpenAI to supercharge mRNA research with genAI
mmm-online.com - April 24 at 5:24 PM
Moderna Stock Jumps On Collaboration With OpenAI: Whats Going On?Moderna Stock Jumps On Collaboration With OpenAI: What's Going On?
msn.com - April 24 at 12:24 PM
Moderna and OpenAI in pact to fast-track drug developmentModerna and OpenAI in pact to fast-track drug development
msn.com - April 24 at 12:24 PM
Moderna and OpenAI Collaborate To Advance mRNA MedicineModerna and OpenAI Collaborate To Advance mRNA Medicine
accesswire.com - April 24 at 8:00 AM
Pfizer and BioNTech commence legal action against Moderna in UK courtPfizer and BioNTech commence legal action against Moderna in UK court
pharmaceutical-technology.com - April 24 at 7:23 AM
Moderna enters contract with Brazil to supply 12.5 million Covid-19 vaccines as part of national vaccination campaignModerna enters contract with Brazil to supply 12.5 million Covid-19 vaccines as part of national vaccination campaign
pharmabiz.com - April 24 at 2:22 AM
South Dakota Investment Council Acquires 44,779 Shares of Moderna, Inc. (NASDAQ:MRNA)South Dakota Investment Council Acquires 44,779 Shares of Moderna, Inc. (NASDAQ:MRNA)
marketbeat.com - April 23 at 9:10 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Centene logo

Centene

NYSE:CNC
Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children's health insurance program, foster care, medicare-medicaid plans, long-term services and support. This segment also provides healthcare products. The Medicare segment offers special needs and medicare supplement, and prescription drug plans. The Commercial segment provides health insurance marketplace product for individual, small, and large group commercials. It also operates clinical healthcare and pharmacies, as well as offers dental services. In addition, the company engages in the government contracts business under the TRICARE program and other healthcare related government contracts. It provides services through primary and specialty care physicians, hospitals, and ancillary providers. Centene Corporation was founded in 1984 and is headquartered in Saint Louis, Missouri.
Elevance Health logo

Elevance Health

NYSE:ELV
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits. The company operates in the pharmacy services business; and markets and offers pharmacy services, including pharmacy benefit management, as well as home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services. In addition, it provides healthcare-related services and capabilities, including utilization management, behavioral health, integrated care delivery, palliative care, payment integrity services, subrogation services, and health and wellness programs, as well as services related to data management, information technology, and business operations. Further, the company is involved in the National Government Services business. The company provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brand names. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is headquartered in Indianapolis, Indiana.
Humana logo

Humana

NYSE:HUM
Humana Inc., together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, life insurance, and other supplemental health benefits, as well as administrative services only products to individuals and employer groups; military services, such as TRICARE T2017 East Region contract; and engages in the operations of pharmacy benefit manager business. Further, it operates pharmacies and senior focused primary care centers; and offers home solutions services, such as home health, hospice, and other services to its health plan members, as well as to third parties. The company sells its products through employers and employees, independent brokers and agents, sales representatives, and digital insurance agencies. The company was formerly known as Extendicare Inc. and changed its name to Humana Inc. in April 1974. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.
Moderna logo

Moderna

NASDAQ:MRNA
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, autoimmune, and cardiovascular diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, influenza, and respiratory syncytial virus, spikevax, and hMPV/PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella zoster virus, and human immunodeficiency virus vaccines; public health vaccines consists of Zika, Nipah, Mpox vaccines; and infectious diseases vaccines, such as lyme and norovirus vaccines. The company also offers systemic secreted and cell surface therapeutics; cancer vaccines, such as personalized cancer, KRAS, and checkpoint vaccines; intratumoral immuno-oncology products; rare disease intracellular therapeutics; and inhaled pulmonary therapeutics. It has strategic alliances and collaborations with AstraZeneca; Merck & Co., Inc; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Chiesi Farmaceutici S.p.A.; Metagenomi, Inc.; Carisma Therapeutics, Inc.; CytomX Therapeutics; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; and The Bill & Melinda Gates Foundation. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.